After the markets closed on Friday, psychedelic drug company Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) released its first quarter financial results...
As we move into the 2nd quarter of 2023, we take a look at Q1 and other trends in the psychedelic medicine sector The post Q1...
The article Which Psychedelic Medicine Companies Have the Best Financials? was originally published on Microdose. As I have written many times before,...
The company asked its shareholders to reject a slate of directors offered up by FCM MM Holdings. The post MindMed Addresses Board Coup, Says It Has...
Better late than never, Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) finally delivered its annual report for the year ending October 2022. Sales revenue...
The company's debts totaled C$136.5 million by the end of 2022. The post Mydecine Cuts Down on Annual Cash Burn Despite Mounting Debt appeared first on...
In an effort to raise funding for commercialization of MDMA-assisted therapy, MAPS partnered with an investment bank to sell equity in its Public Benefit...
Upon the closing which occurred on March 22, 2023, the purchase price was adjusted from... The post SciSparc completes the sale of a 49% interest in...
Source: Streetwise Reports 03/21/2023 Treating traumatic brain injury with alternative pharmaceuticals is delicate work. Now one Canadian...
The article Lucy Scientific Acquires Psychedelic Assets from Wesana Health was originally published on Microdose. Last month, a new psychedelic firm joined...